Another stock that's quickly moving within range of triggering a near-term breakout trade is Genetic Technologies ( GENE), which provides genetic testing services. This stock is off to a strong start in 2013, with shares up sharply by 24%. If you look at the chart for Genetic Technologies, you'll notice that this stock has been uptrending strong for the last two months, with shares moving higher from its low of $2.10 to its recent high of $2.90 a share. During that uptrend, shares of GENE have been consistently making higher lows and higher highs, which is bullish technical price action. That move has quickly pushed shares of GENE within range of triggering a near-term breakout trade. Market players should now look for long-biased trades in GENE if it manages to break out above some near-term overhead resistance levels at $2.75 to $2.80 a share and then once it takes out more resistance at $2.90 to its 200-day at $3.14 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 38,979 shares. If that breakout triggers soon, then GENE will set up to re-test or possibly take its next major overhead resistance levels at $3.40 to $3.80 a share. Any high-volume move above those levels will then put $3.95 to $4.22 into range for shares of GENE. Traders can look to buy GENE off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $2.47 a share or around more support at $2.36 a share. One can also buy GENE off strength once it clears those breakout levels with volume and then simply use a stop that sits right below its 50-day at $2.47 a share. I would add to either position once GENE clears its 200-day at $3.14 a share with heavy upside volume.